Figures & data
Table 1. Demographic characteristics and comorbidities by refractory status.
Table 2. Annual all-cause and POS-related healthcare costs per patient by refractory status in each calendar year.
Figure 2. Anti-epileptic drug treatment patterns among patients with refractory epilepsy with partial onset seizures.
![Figure 2. Anti-epileptic drug treatment patterns among patients with refractory epilepsy with partial onset seizures.](/cms/asset/a03550e0-33f3-48cd-9665-692d3e1a0efa/ijme_a_751918_f0002_b.jpg)
Figure 3. Most common anti-epileptic monotherapies and combination therapies among patients with refractory epilepsy with partial onset seizures.
![Figure 3. Most common anti-epileptic monotherapies and combination therapies among patients with refractory epilepsy with partial onset seizures.](/cms/asset/3af19cd0-a0fe-458d-a5f5-f34ff94d4496/ijme_a_751918_f0003_b.jpg)
Table 3. Most common therapy add-ons and switches among patients with refractory epilepsy with partial onset seizures.